Search
for

    Sort by

    Research 91–120 of 1000+

    1. Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study Annals of Oncology · 2007 · 29 citations
    2. Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer Breast Care · 2021 · 11 citations
    3. Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors Journal of international medical research · 2014 · 12 citations
    4. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer Cureus · 2018 · 3 citations
    5. Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study Drug Design Development and Therapy · 2025
    6. The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study JAAD Case Reports · 2025
    7. 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial Journal of the American Academy of Dermatology · 2024
    8. Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved] Faculty of 1000 Research Ltd · 2021
    9. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer 2008 · 108 citations
    10. Systematic Review of the Risk of Permanent Alopecia with Docetaxel Treatment for Breast Cancer Journal of clinical case reports · 2016
    11. Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients Journal of the European Academy of Dermatology and Venereology · 2015 · 8 citations
    12. A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting Medical hypotheses · 1998 · 5 citations
    13. Kang'ai Injection Combined with FLO Chemotherapy in the Treatment of Advanced Gastric Cancer:A Clinical Observation of 40 Cases Zhongguo shiyan fangjixue zazhi · 2012 · 1 citations
    14. A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative) Future Oncology · 2025
    15. The clinical observation of first-line docetaxel and carboplatin treatment for elderly patients with non-selective non-small-cell lung cancer Journal of Clinical Medicine in Practice · 2012
    16. IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER The Journal of Urology · 2009
    17. Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI) European Journal of Cancer · 2010 · 93 citations
    18. Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen Frontiers in oncology · 2023
    19. Clinical Value Analysis of Pemetrexed Combined with Cisplatin in the Treatment of Non-Small Cell Lung Cancer Deleted Journal · 2023
    20. The effectiveness of fermented wheat germ extract as an adjunct therapy in the treatment of cancer: A systematic review JBI Library of Systematic Reviews · 2012 · 5 citations
    21. Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer Figshare · 2023
    22. Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer Figshare · 2023
    23. S88 Does cone beam computed tomography decrease CTV's margins in prostate cancer radiation treatment? European Urology Supplements · 2009
    24. The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment. Journal of Clinical Oncology · 2024 · 1 citations
    25. [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer]. DOAJ (DOAJ: Directory of Open Access Journals) · 2012 · 3 citations
    26. Evaluation of Short-Term Efficacy and Long-Term Oncologi-Cal Outcomes of Different Paclitaxels Plus Platinum Regi-Mens in the Treatment of Serous Ovarian Cancer—A Real World Study Research Square (Research Square) · 2021
    27. A Clinical Evaluation of Guduchi (Tinospora cordifolia) and Yashtimadhu (Glycyrrhiza glabra) as Chemopreventive Agent in Cancer Treatment Asian Journal of Oncology · 2019 · 7 citations
    28. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    29. α‐Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo‐prevention International Journal of Dermatology · 2006 · 9 citations
    30. A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin⋅hydrochloride for thyroid cancer treatment <i>in vitro</i> and <i>in vivo</i> Drug Delivery · 2018 · 27 citations